department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Orencia · pharmadog

pharmadog
drugs
Orencia

drug

patient view →

abatacept

Marketedupdated 2mo ago

by Bristol-Myers Squibb Co

Approved

community read0 votes

indications

investigational

Rheumatoid Arthritis

all catalysts(1)

phase 3 initiation · 1

News(0)

no news has mentioned this drug yet

brand

Orencia

generic

abatacept

indication

Graft Versus Host Disease (GVHD)

phase

marketed

phase 3 initiation

University of Thessaly — abatacept (Phase III Trial Initiation)

Data sources

ClinicalTrials.gov

last refreshed 12m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 4

drugImmunology1 co-mentions · 1 sources
companyUniversity of Thessaly1 co-mentions · 1 sources
tagImmunology1 co-mentions · 1 sources
tagRheumatoid Arthritis1 co-mentions · 1 sources

Trials studying abatacept

phase1Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjectscompletedn=300
phase2Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxisrecruitingn=160
phase1Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantationrecruitingn=41
phase2A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantationrecruitingn=358
phase2Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplantactive not recruitingn=30
phase2Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Diseaserecruitingn=38
phase2Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantationcompletedn=43
phase3Abatacept in Immune Checkpoint Inhibitor Myocarditisrecruitingn=390

more trials →